FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sun Pharmaceutical Industries Wal-Fex D Fexofenadine HCl 60 mg/ Recall

Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/ Extended-Release Tablets…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class II
Reported by FDA
Jun 26, 2019
Recall ID
D-1389-2019
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Wal-Fex D Fexofenadine HCl 60 mg/ starting Jun 5, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1389-2019 on Jun 26, 2019. Reason: Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit. Status: Terminated.

Why it was recalled

Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Product description

Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/ Extended-Release Tablets, USP, Allergy & Congestion, 30-count box. Distributed by: Walgreen Co. 200 Wilmore Rd. Deerfield, IL 40015. Made in India. UPC 3 11917 19454 7

Lot numbers, UPCs & expiration codes

Lot: GKS1014, EXP 09/2019; GKT0484A, EXP 04/2020

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1389-2019
Classification
Class II
Status
Terminated
Recall initiated
Jun 5, 2019
FDA report date
Jun 26, 2019
Quantity
14,399 30-count units
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-1389-2019, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
83025
Address
270 Prospect Plains Rd
Code information
Lot: GKS1014, EXP 09/2019; GKT0484A, EXP 04/2020
Postal code
08512-3605
Report date
Jun 26, 2019
Product type
Drugs
Recall number
D-1389-2019
Classification
Class II
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
14,399 30-count units
Termination date
Jan 8, 2021
Reason for recall
Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit
Voluntary / mandated
Voluntary: Firm initiated
Product description
Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/ Extended-Release Tablets, USP, Allergy & Congestion, 30-count box. Distributed by: Walgreen Co. 200 Wilmore Rd. Deerfield, IL 40015. Made in India. UPC 3 11917 19454 7
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 5, 2019
Initial firm notification
Letter
Center classification date
Jun 14, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1389-2019, published Jun 26, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls